In-vitro Diagnostics Market overview 2018-2024 | Key Players: Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied, Danaher

The In-vitro diagnostics Market size is set to exceed USD 92 billion by 2024; according to a new research report by Global Market Insights.

Market Overview:

Rising adoption rate of automated laboratory equipment and machines will boost in-vitro diagnostics market growth over the coming years. Developed countries such as Germany and UK have progressed well in adoption of advanced technology enabling modifications in the medical diagnostic equipment and machinery. Growing implementation of technologically advanced diagnosis equipment should foster business growth. Increased accuracy offered by diagnostic devices will improve performance of surgical procedures enhancing in-vitro diagnostics industry growth in upcoming years.

Growing preference of elderly population towards personalized medicines for treatment of numerous chronic disorders will propel in-vitro diagnostics market growth over forecast timeframe. Extended use of in-vitro diagnosis devices to develop novel therapies that treat disorder at molecular level will accelerate industry growth. More than 22 million people in Germany are in age group of 60-80 years and majority of them suffer from at least one chronic disorder that will upsurge the demand for in-vitro diagnosis.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2820

Increase in the number of pathology laboratories globally will influence the industry growth positively. Pathology labs are well equipped with technologically advanced diagnostic devices increasing preference amongst the geriatric population. Also, availability of skilled technicians in-vitro diagnostic laboratories should augment industry growth. In U.S., around 18,000 pathologists are actively practicing and around 93% of them are board certified escalating the business growth in forth coming years.

However, industry growth is hampered by the high cost associated with the diagnostic procedures. High costs of the diagnostic procedures will act as a major restraint affecting industry growth by creating affordability issues.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2820

Regional Analysis:

U.S. in-vitro diagnostics market held an enormous regional share of 89.7% in 2017 and will have similar growth trends in the near future. Growing burden of chronic diseases and viral infections have surged the demand for in-vitro diagnostic procedures. In U.S., around 3.9 million people are infected with hepatitis C that establishes a strong demand for advanced diagnostic devices to sustain the health of patients.

Germany in-vitro diagnostics market should grow at 4.6% during the forecast period owing to increasing technological advancements that have added improvisations in the existing in-vitro diagnostic devices. Furthermore, ageing demographic condition in Germany will have a positive impact on industry in foreseeable future. The geriatric population of Germany in 2017 was around 22 million that should positively influence in-vitro diagnostic market growth.

Chapter 3. In-vitro Diagnostics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.1.1.  Growing rate of healthcare infections particularly in North America

3.3.1.2.  Increasing adoption rate of automated diagnostic machine & equipment in Europe

3.3.1.3.  Rising geriatric population preferring personalized medicines in Asia Pacific

3.3.1.4.  Surging number of pathology labs and services equipped with advanced diagnostics machine

3.3.1.5.  Increasing awareness regarding viral disease detection in the U.S.

3.3.2.  Industry pitfalls and challenges

3.3.2.1.  Excessive cost of diagnosis service

3.4. Growth potential analysis

3.4.1.  By type

3.4.2.  By technology

3.4.3.  By application

3.4.4.  By end-user

3.5. Regulatory landscape

3.5.1.  U.S.

3.5.2.  Europe

3.6. Porter’s analysis

3.7. Competitive landscape, 2017

3.7.1.  Strategy dashboard

3.8. PESTEL analysis

Key Players:

Some of the prominent industry players operating in the in-vitro diagnostics industry are Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied, Danaher, Grifols, Johnson & Johnson, Luminex, Roche Diagnostics, Siemens, Sorin, Thermo Fisher and Qiagen. Key industry players focus on strategic initiatives to improve their market position.

Strategic initiatives adopted by major companies include mergers, acquisitions and new product launch that fetch them sustainable profits. For instance, in March 2018, Danaher acquired Integrated DNA Technologies. This acquisition will expand the company’s product portfolio and aid revenue generation for the company.

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.